China’s healthcare sector will significantly transform as the government intensifies its anti-corruption campaign. The authorities are determined to tackle corruption in all aspects of the healthcare system, including pharmaceutical companies, manufacturing, hospitals, and medical insurance funds. This sweeping crackdown aims to promote transparency, improve healthcare services, and restore public trust. This article will explore the implications of this anti-graft campaign and its potential impact on China’s healthcare sector. Corruption has long plagued China’s healthcare system, leading to a lack of
